Emily J. Gilmore

Emily J. Gilmore, MD is a Professor of Neurology and Neurosurgery at Yale School of Medicine, where she serves as Clinical Chief of the Division of Neurocritical Care and Emergency Neurology, Director of the Neurosciences Intensive Care Unit, and Co-Director of Neurotrauma. She co-leads the Critical Care EEG Program and holds appointments in both Neurology and Neurosurgery.

• Board-certified in Clinical Neurophysiology (AB of Clinical Neurophysiology, 2015)
• Director of Neuro-ICU and Neuromonitoring programs
• Principal Investigator for national neurotrauma trials

Her research focuses on physiologic biomarkers from multimodal brain monitoring to personalize care for acute brain injury patients. Key areas include:

• Traumatic Brain Injury (TBI)
• Status Epilepticus management
• Subarachnoid Hemorrhage
• Stroke and Cardiac Arrest outcomes

Recent studies highlighted her work on:

• Genetic risk factors (APOE ε4, polygenic profiling) for hemorrhage
• Quantitative EEG and neuroimaging for epilepsy prediction
• Pupillometry as a prognostic tool in stroke
• Automated CT analysis for post-traumatic epilepsy risk

Scientific recognition includes:

• A.B. Baker Teacher Recognition Award (2020)
• Fellow of the American Clinical Neurophysiology Society (2019) and Neurocritical Care Society (2020)
• Board Member, American Board of Clinical Neurophysiology (2022)

As a clinical investigator, she leads the BOOST3 Phase 3 trial for TBI and contributes to ASPIRE and BEACH stroke studies. Her lab collaborates with teams at MGH and UTSW on biomarker research.